DK163582A - Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning - Google Patents

Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning Download PDF

Info

Publication number
DK163582A
DK163582A DK163582A DK163582A DK163582A DK 163582 A DK163582 A DK 163582A DK 163582 A DK163582 A DK 163582A DK 163582 A DK163582 A DK 163582A DK 163582 A DK163582 A DK 163582A
Authority
DK
Denmark
Prior art keywords
physiologically active
active substance
substance
gel filtration
gel
Prior art date
Application number
DK163582A
Other languages
English (en)
Other versions
DK158230B (da
DK158230C (da
Inventor
Katsuyuki Haranaka
Original Assignee
Asahi Chemical Ind
Dainippon Pharmaceuical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind, Dainippon Pharmaceuical Co Ltd filed Critical Asahi Chemical Ind
Priority to DK163582A priority Critical patent/DK158230C/da
Publication of DK163582A publication Critical patent/DK163582A/da
Publication of DK158230B publication Critical patent/DK158230B/da
Application granted granted Critical
Publication of DK158230C publication Critical patent/DK158230C/da

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK163582A 1982-04-07 1982-04-07 Fremgangsmaade til rensning af et proteinlignende fysiologisk aktivt stof med antitumorvirkning og det proteinlignende fysiologisk aktive stof, der er renset ved denne fremgangsmaade DK158230C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK163582A DK158230C (da) 1982-04-07 1982-04-07 Fremgangsmaade til rensning af et proteinlignende fysiologisk aktivt stof med antitumorvirkning og det proteinlignende fysiologisk aktive stof, der er renset ved denne fremgangsmaade

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK163582 1982-04-07
DK163582A DK158230C (da) 1982-04-07 1982-04-07 Fremgangsmaade til rensning af et proteinlignende fysiologisk aktivt stof med antitumorvirkning og det proteinlignende fysiologisk aktive stof, der er renset ved denne fremgangsmaade

Publications (3)

Publication Number Publication Date
DK163582A true DK163582A (da) 1983-10-08
DK158230B DK158230B (da) 1990-04-16
DK158230C DK158230C (da) 1990-09-17

Family

ID=8106749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK163582A DK158230C (da) 1982-04-07 1982-04-07 Fremgangsmaade til rensning af et proteinlignende fysiologisk aktivt stof med antitumorvirkning og det proteinlignende fysiologisk aktive stof, der er renset ved denne fremgangsmaade

Country Status (1)

Country Link
DK (1) DK158230C (da)

Also Published As

Publication number Publication date
DK158230B (da) 1990-04-16
DK158230C (da) 1990-09-17

Similar Documents

Publication Publication Date Title
ATE23540T1 (de) Verfahren zur reinigung einer physiologisch aktiven substanz mit antitumor aktivitaet.
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
Ismail et al. Pharmacokinetics of 125I-labelled venom from the scorpion Androctonus amoreuxi, Aud. and Sav.
IL73734A0 (en) Process for purifying factor viii:c
Seidah et al. A rapid high-performance liquid chromatography purification method of lodinated polypeptide hormones
EP0239565A3 (en) Method of and apparatus for separating proteins
Hara et al. An improved method of the purification of ricin D
Martenson et al. Studies on the acid‐extractable proteins of bovine brain white matter
MA20068A1 (fr) Nouveaux acides flavone-carboxyliques-4; leur methode de preparation et leur application therapeutique.
Koo Characterization of growth-inhibitory activities associated with an α-macroglobulin of mice
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
SUGAHARA et al. Two molecular forms of Clostridium perfringens α-toxin associated with lethal, hemolytic and enzymatic activities
US4658017A (en) Method for the large scale purification of human fibroblast interferon
GR3019705T3 (en) Purification of human interleukin-4 secreted from an escherichia coli mutant
ES8304150A1 (es) "un procedimiento para purificar una sustancia proteinica fisiologicamente activa que tiene actividad antitumoral".
Davis et al. Electrophoretic characteristics of macroamylasemic serum
Paus Immunoadsorbent affinity purification of the two enzyme forms of α-mannosidase from Phaseolus vulgaris
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
KR900006011A (ko) 성장 호르몬-유사 물질로부터 응집체를 분리시키는 크로마토그래피법
US5023320A (en) Process for the purification of physiologically active substance having antitumor activity
Fine et al. Affinity chromatography of antiserum to a gram negative organism
Homma et al. THE CHROMATOGRAPHIC PURIFICATION OF BACTERIOPHAGE AND ENDOTOXIN OF PSEUDOMONAS AERUGJNOSA
Rubin et al. SPECIFIC HETEROLOGOUS ENHANCEMENT OF IMMUNE RESPONSES: VI. Partial Purification of a Nonspecific Enhancing Factor from Supernates of Allogeneically Stimulated Human Lymphocyte Cell Lines
Parman Comparison of carboxymethyl-cellulose cation-exchange chromatography and high-performance liquid chromatography in the purification of guinea-pig insulin from pancreatic extracts
Martypé et al. Characterization and partial purification of normal and tumor associated transplantation antigens of Rauscher leukemia cells

Legal Events

Date Code Title Description
PBP Patent lapsed
PUP Patent expired